Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10401
CALL
E.W. Scripps
SSP
$320M
| $140K | ﹤0.01% |
17,500
+5,000
| +40% | +$33.6K |
|
10402
Constellium
CSTM
$4.01B
| $140K | ﹤0.01% |
7,004
-49,681
| -88% | -$870K |
|
10403
PUT
Petco
WOOF
$805M
| $140K | ﹤0.01% |
44,200
-75,400
| -63% | -$260K |
|
|
AHRT
10404
AH Realty Trust
AHRT
$506M
| $140K | ﹤0.01% |
11,289
-77,583
| -87% | -$855K |
|
|
GAN
10405
CALL
DELISTED
GAN Ltd
GAN
| $140K | ﹤0.01% |
88,300
-1,000
| -1% | -$1.33K |
|
10406
PUT
Turning Point Brands
TPB
$1.75B
| $139K | ﹤0.01% |
5,300
-1,700
| -24% | -$38.9K |
|
10407
CALL
Integra LifeSciences
IART
$1.43B
| $139K | ﹤0.01% |
+3,200
| New | +$126K |
|
10408
CALL
Selective Insurance
SIGI
$5.62B
| $139K | ﹤0.01% |
1,400
-3,900
| -74% | -$400K |
|
10409
CALL
Heron Therapeutics
HRTX
$63.9M
| $139K | ﹤0.01% |
81,900
+70,600
| +625% | +$77.7K |
|
10410
CALL
Atlanticus Holdings
ATLC
$1.56B
| $139K | ﹤0.01% |
3,600
+2,500
| +227% | +$78.7K |
|
10411
PUT
VirTra
VTSI
$36.6M
| $139K | ﹤0.01% |
14,700
+10,900
| +287% | +$71K |
|
10412
PUT
PennantPark Floating Rate Capital
PFLT
$730M
| $139K | ﹤0.01% |
11,500
+4,500
| +64% | +$49.1K |
|
|
ALPN
10413
CALL
DELISTED
Alpine Immune Sciences Inc
ALPN
| $139K | ﹤0.01% |
7,300
+5,600
| +329% | +$77.8K |
|
10414
PUT
Gladstone Capital
GLAD
$446M
| $139K | ﹤0.01% |
6,500
-5,350
| -45% | -$107K |
|
10415
PUT
Allogene Therapeutics
ALLO
$708M
| $139K | ﹤0.01% |
43,300
+1,600
| +4% | +$4.54K |
|
10416
Culp Inc
CULP
$42.2M
| $139K | ﹤0.01% |
23,981
+8,110
| +51% | +$44.1K |
|
|
LAZR
10417
PUT
DELISTED
Luminar Technologies
LAZR
| $139K | ﹤0.01% |
2,747
-8,140
| -75% | -$405K |
|
10418
PUT
Zegna
ZGN
$3.69B
| $139K | ﹤0.01% |
+12,000
| New | +$143K |
|
10419
PUT
IDEAYA Biosciences
IDYA
$3.49B
| $139K | ﹤0.01% |
3,900
-5,600
| -59% | -$167K |
|
10420
PUT
Bain Capital Specialty
BCSF
$814M
| $139K | ﹤0.01% |
9,200
-3,600
| -28% | -$54.8K |
|
10421
PUT
CEL-SCI Corp
CVM
$26.9M
| $138K | ﹤0.01% |
1,693
-110
| -6% | -$6.85K |
|
10422
PUT
Vaxcyte
PCVX
$8.64B
| $138K | ﹤0.01% |
2,200
| – | – |
|
10423
PUT
Applied Industrial Technologies
AIT
$13.3B
| $138K | ﹤0.01% |
800
-10,300
| -93% | -$1.67M |
|
10424
CALL
Matrix Service
MTRX
$335M
| $138K | ﹤0.01% |
14,100
-8,300
| -37% | -$90.1K |
|
10425
CALL
Terreno Realty
TRNO
$7.43B
| $138K | ﹤0.01% |
2,200
+1,700
| +340% | +$96.7K |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.